Roles of Heterotrimeric GTP-Binding Proteins in the Progression of Heart Failure
Access this Article
Search this Article
Heart failure is a major cause of death in developed countries, and the development of an epoch-making cure is desired from the viewpoint for improving the quality of life and reducing the medical cost of the patient. The importance of neurohumoral factors, such as angiotensin (Ang) II and catecholamine, for the progression of heart failure has been supported by a variety of evidence. These agonists stimulate seven transmembrane-spanning receptors that are coupled to heterotrimeric GTP-binding proteins (G proteins). Using specific pharmacological tools to assess the involvement of G protein signaling pathways, we have revealed that <I>α</I> subunit of G<SUB>q</SUB> (G<I>α</I><SUB>q</SUB>) activates Ca<SUP>2+</SUP>-dependent hypertrophic signaling through diacylglycerol-activated transient receptor potential canonical (TRPC) channels (TRPC3 and TRPC6: TRPC3/6). In contrast, activation of G<I>α</I><SUB>12</SUB> family proteins in cardiomyocytes confers pressure overload–induced cardiac fibrosis via stimulation of purinergic P2Y<SUB>6</SUB> receptors induced by extracellular nucleotides released from cardiomyocytes. In fact, direct or indirect inhibition of TRPC3/6 or P2Y<SUB>6</SUB> receptors attenuates pressure overload–induced cardiac dysfunction. These findings will provide a new insight into the molecular mechanisms underlying pathogenesis of heart failure.
- Journal of Pharmacological Sciences
Journal of Pharmacological Sciences 117(1), 1-5, 2011-09-20
The Japanese Pharmacological Society